Avalo Therapeutics, Inc.

AVTX · XNAS

CIK 1534120fmd_15BSEZ369CF07MVZW79XPD481SManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods

Ratios computed from the standardized statements. Select a value to open its proof.